ReviewAbdominal radiology (New York)2019
Current controversy, confusion, and imprecision in the use and interpretation of rectal MRI.
Review in Abdominal radiology (New York), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 35 citations in OpenAlex.
- Local recurrence in rectal cancer: from detection to structured reporting.Abdominal radiology (New York) · 2026Article
- Overstaging of the mesorectal fascia following neoadjuvant therapy and its impact on therapeutic management: a single-center retrospective cohort study of 506 mesorectal fascia positive patients.Journal of gastrointestinal oncology · 2026Article
- Near Complete Response: An Opportunity for Organ Preservation in Rectal Cancer.Annals of surgical oncology · 2025Article
- Radiomic Features of Mesorectal Fat as Indicators of Response in Rectal Cancer Patients Undergoing Neoadjuvant Therapy.Tomography (Ann Arbor, Mich.) · 2025Article
- Rectal Cancer and Lateral Lymph Node Staging: Interobserver Agreement and Success in Predicting Locoregional Recurrence.Diagnostics (Basel, Switzerland) · 2024Article
- Interdisciplinary Spanish consensus on a watch-and-wait approach for rectal cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024Article
- Multimodality Imaging to Direct Management of Primary and Recurrent Rectal Adenocarcinoma Beyond the Total Mesorectal Excision Plane.Radiology. Imaging cancer · 2024Review
- Interpretable machine learning model to predict surgical difficulty in laparoscopic resection for rectal cancer.Frontiers in oncology · 2024Review
- Pearls and pitfalls of structured staging and reporting of rectal cancer on MRI: an international multireader study.The British journal of radiology · 2023Article
- Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel.Abdominal radiology (New York) · 2023Review
- The optimized rectal cancer MRI protocol: choosing the right sequences, sequence parameters, and preparatory strategies.Abdominal radiology (New York) · 2023Review
- Radiomic Features Are Predictive of Response in Rectal Cancer Undergoing Therapy.Diagnostics (Basel, Switzerland) · 2023Article
- Achieving a Cure Without Total Mesorectal Excision in Rectal Adenocarcinoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023Review
- Significant improvement after training in the assessment of lateral compartments and short-axis measurements of lateral lymph nodes in rectal cancer.European radiology · 2023Article
- Deep learning models for preoperative T-stage assessment in rectal cancer using MRI: exploring the impact of rectal filling.Frontiers in medicine · 2023Article
- Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training.Insights into imaging · 2022Article
- An MRI-based pelvimetry nomogram for predicting surgical difficulty of transabdominal resection in patients with middle and low rectal cancer.Frontiers in oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
Abstract
There has been a rapid increase in the utilization of MRI in rectal cancer staging in the USA essentially replacing endorectal ultrasound and mimicking the trend in Europe seen in the 1990s and 2000s. Accompanying this trend, there is a demand, and recognized need, for greater precision and clarification of confusing, misunderstood and poorly understood concepts, facts, statements and nomenclature regarding rectal cancer and the use of pelvic MRI for diagnosis. As such, this Review, part evidence-based and part expert opinion, will attempt to elucidate and clarify several concepts the authors have encountered in 25 years of imaging rectal cancer, focusing on MRI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.